The Patent Finder

Pharmacopeia, Inc.

Also on record
Records under this name other than the patents Pharmacopeia, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 5 patents it holds.

Back to Pharmacopeia, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,763,616Piperazine-Piperidines with CXCR3 Antagonist Activity
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,786,124Novel Heterocyclic Substituted Pyridine Compounds with CXCR3 Antagonist Activity
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,902,199Heterocyclic Substituted Piperazine Compounds with CXCR3 Antagonist Activity
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 7,820,649Quinazolinone and Isoquinolinone Acetamide Derivatives
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,906,5042-(1-OXO-1H-ISOQUINOLIN-2-YL)ACETAMIDE Derivatives
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 7,902,1876-Substituted 2-(BENZIMIDAZOLYL)PURINE and Purinone Derivatives for Immunosuppression
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 7,759,353Substituted Spiro Iminopyrimidinones as Aspartyl Protease Inhibitors, Compositions, and Methods of Treatment
Held by another company
In force
 · High confidence
In forceHigh confidence
US 8,314,091N-Benzyl,n'-Arylcarbonylpiperazine Derivatives
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,759,3521-(4-Ureidobenzoyl)PIPERAZINE Derivatives
Lapsed on the fee record
Ended Jun 24, 2026 · High confidence
Lapsed on the fee recordEnded Jun 24, 2026High confidence
US 7,807,6862-(4-OXO-4H-QUINAZOLIN-3-YL) Acetamides and Their Use as Vasopressin V3 Antagonists
Formerly held
Term ended
Term ended Mar 10, 2026 · High confidence
Term endedTerm ended Mar 10, 2026High confidence
10 of 161 patents shown.
Pro members see all 161.
Pro members: see all 161 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited